NEWCLIP TECHNICS
Charlotte Lauras is a seasoned marketing professional with extensive experience in the healthcare sector. Currently serving as Global Marketing Director at Newclip Technics since January 2024, Charlotte previously held several key positions at Urgo Medical from January 2015 to September 2023, including Business Unit Head for Benelux & Distributor Markets and Marketing & Professional Relations Director for France. Charlotte has a proven track record of driving significant business transformations, achieving impressive sales growth, and managing multi-functional teams across various regions. With a strong educational background including a Master's degree from HEC Paris, Charlotte has consistently demonstrated expertise in strategic planning, market analysis, and brand management throughout a progressive career in notable companies such as URGO Group, Unilever, and Big C Vietnam.
This person is not in any teams
NEWCLIP TECHNICS
Founded in 2002, NEWCLIP TECHNICS is based near Nantes, in Western France. The company designs, manufactures and markets various ranges of osteosynthesis implants for elective surgery or traumatology. Innovation, quality and performance are at the heart of our company's values. - Innovation: We are committed to developing innovative products through an ambitious R&D program, as confirmed by numerous international patents such as the prize-winning (French Ministry of Research) polyaxial locking mechanism Dual Tech System (DTS®). - Quality: We care deeply about constantly improving our products to maintain the highest standards of quality and we offer products well-adapted to the market, in keeping with current international standards. NEWCLIP TECHNICS has been granted ISO 13485: 2003 Certification. - Performance: With our top-of-the-range machinery and equipment, we continue to invest in the latest cutting-edge technologies to design and turn out innovative high-performance products. Our customers' satisfaction is a priority and thanks to our latest design tools and production means, we are gradually extending our range of products. The company is already established in 50 countries (Europe, USA, Japan, Australia and South Africa...) and sets out to provide high-tech solutions to the latest surgical trends.